Search

Your search keyword '"Sarcoma -- Drug therapy -- Development and progression -- Patient outcomes"' showing total 3 results
Start Over Descriptor "Sarcoma -- Drug therapy -- Development and progression -- Patient outcomes"
3 results on '"Sarcoma -- Drug therapy -- Development and progression -- Patient outcomes"'

1. NEC OncoImmunity publishes research using its neoantigen prediction technology showing improved outcome in sarcoma patients treated with cancer immunotherapy

Subjects
Oncology, Experimental -- Technology application, Sarcoma -- Drug therapy -- Development and progression -- Patient outcomes, Cancer patients -- Drug therapy -- Patient outcomes, Immunotherapy -- Technology application, Cancer -- Care and treatment -- Development and progression -- Patient outcomes -- Drug therapy -- Research, Tumor antigens -- Technology application, Technology application, General interest, News, opinion and commentary
Abstract

OSLO: NEC OncoImmunity AS has issued the following news release: NEC OncoImmunity AS (NOI) today announced it has published a study that describes the use of its artificial intelligence (AI) [...]

Published
2023

2. NEC OncoImmunity publishes research using its neoantigen prediction technology showing improved outcome in sarcoma patients treated with cancer immunotherapy

Subjects
Oncology, Experimental -- Technology application, Sarcoma -- Drug therapy -- Development and progression -- Patient outcomes, Cancer patients -- Drug therapy -- Patient outcomes, Immunotherapy -- Technology application, Cancer -- Care and treatment -- Development and progression -- Patient outcomes -- Drug therapy -- Research, Tumor antigens -- Technology application, Technology application, News, opinion and commentary
Abstract

OSLO, Norway--(BUSINESS WIRE)--Oct 17, 2023-- NEC OncoImmunity AS (NOI) today announced it has published a study that describes the use of its artificial intelligence (AI) based neoantigen prediction technology to [...]

Published
2023

3. NEC OncoImmunity publishes research using its neoantigen prediction technology showing improved outcome in sarcoma patients treated with cancer immunotherapy

Subjects
Oncology, Experimental -- Technology application, Sarcoma -- Drug therapy -- Development and progression -- Patient outcomes, Cancer patients -- Drug therapy -- Patient outcomes, Immunotherapy -- Technology application, Cancer -- Care and treatment -- Development and progression -- Patient outcomes -- Drug therapy -- Research, Tumor antigens -- Technology application, Technology application, Business, Business, international
Abstract

OSLO, Norway -- NEC OncoImmunity AS (NOI) today announced it has published a study that describes the use of its artificial intelligence (AI) based neoantigen prediction technology to demonstrate that [...]

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results